Allosource is a 501(c)(3) organization based in Centennial, Colorado, registered in 1996, with $180,054,973 in FY2024 revenue. CharityIndex grades it A+, and it directs about 93% of spending to programs.
Revenue (FY2024)
$180.1M
▲ 4.2% vs prior year
Health median: $840K
Expenses (FY2024)
$174.8M
Net assets
$102.4M
Employees
611
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Allosource: 93% to programs · $0 to raise $100 earns a A+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Allosource: 7 mo reserves · +3% margin earns a A on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Allosource: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Allosource: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Allosource responsibly processes and distributes human donated tissue that enhances and saves lives.
Research, education, and training: allosource is dedicated to advancing the use of transplantable allogeneic cells and tissue through pioneering research. in 2024, allosource continued its research in the areas of pediatric orthopedics and cellular therapies, expanding the impact of donation by finding additional uses for tissue. allosource worked with the 501(c)(3) organizations that recover tissue to reduce tissue contamination. we also provided educational opportunities to our partner organ procurement organizations to help them increase donation rates in their respective communities.
Charitable contribution activity: in alignment with our mission, allosource provided grants to support 501(c)(3) organizations that are involved in organ, eye, and tissue donation, s.t.e.m. education, as well as patient physical and mental healing. in 2024, allosource gave grants to three organizations to further tissue donation and transplantation awareness and processes and made charitable contributions to six other 501(c)(3) organizations through direct and matching employee financial donations.
Revenue grew from $134.7M (FY2013) to $180.1M (FY2024) across 12 reported years.
Financial snapshot
Operating margin
2.9%
Revenue exceeded expenses in the latest fiscal year.
Total assets
$150.4M
Total liabilities
$48.1M
Net assets
$102.4M
Salaries & benefits
$56.2M
32% of expenses
Board members
6
5 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2024 | $180,054,973▲4.2% | $174,807,080▲0.5% | $102,354,389▲6.2% | $150,410,958▼1.2% | 990 |
| 2023 | $172,749,079▲9.6% | $173,901,699▲5.4% | $96,370,383▲0.6% | $152,171,181▲0.5% | 990 |
| 2022 | $157,659,866▲1.1% | $164,951,555▲10.0% | $95,767,569▼8.7% | $151,465,252▼4.9% | 990 |
| 2021 | $155,893,092▲13.6% | $149,970,189▲5.6% | $104,869,918▲6.3% | $159,280,859▲2.5% | 990 |
| 2020 | $137,184,154▼6.1% | $142,008,508▲0.5% | $98,621,367▼3.5% | $155,465,890▼2.7% | 990 |
| 2019 | $146,066,508▼10.2% | $141,353,159▼7.8% | $102,147,928▲5.8% | $159,803,280▲6.8% | 990 |
| 2018 | $162,715,599▲16.0% | $153,235,852▲10.7% | $96,520,865▲19.3% | $149,573,472▲14.7% | 990 |
| 2017 | $140,242,520▼6.0% | $138,371,793▼5.6% | $80,939,057▲2.4% | $130,447,356▲2.7% | 990 |
| 2016 | $149,165,655▼7.0% | $146,586,731▼4.8% | $79,068,330▲3.4% | $127,046,532▼4.8% | 990 |
| 2015 | $160,378,712▲9.7% | $153,918,214▲6.4% | $76,489,406▲9.2% | $133,424,987▲17.9% | 990 |
| 2014 | $146,179,354▲8.5% | $144,655,310▲12.5% | $70,028,908▲2.2% | $113,184,439▲0.6% | 990 |
| 2013 | $134,726,503 | $128,601,496▲3.5% | $68,504,864▲9.8% | $112,482,172▲11.0% | 990 |
| 2012 | — | $124,269,352▲18.9% | $62,379,857▲10.5% | $101,310,112▲6.7% | 990 |
| 2011 | — | $104,483,449▲20.3% | $56,430,687▲18.5% | $94,975,597▲21.8% | 990 |
| 2010 | — | $86,834,763 | $47,624,512 | $77,992,910 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Dean H Elliott — $754,854 (0.43% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Dean H Elliott | President, Ceo | 40 | $754,854 |
| Thomas A Cycyota | Former President | 0 | $668,532 |
| Yan Deng | Chief Financial Officer | 40 | $348,762 |
| Kenneth Hammons | Svp Operations | 40 | $331,147 |
| Kevin L Whitten | Chief Commercial Officer | 40 | $324,650 |
| Hannis W Thompson III | Medical Director | 40 | $319,169 |
| Brian R Bobka | Vp International | 40 | $284,474 |
| Andrew Abell | Head Strategic Accounts | 40 | $262,571 |
| Kimberly Meyer | Svp Quality & Performance Excellence | 40 | $261,271 |
| Inga Gurevich | Associate Medical Director | 40 | $259,938 |
| Andrea Ho | Associate Medical Director | 40 | $256,935 |
| Michelle Zeppelin | Svp Human Resources | 40 | $256,157 |
| Carolyn Rorick | Sr Director Product Development Innovation & Clinical Affairs | 40 | $252,858 |
| Dr Harry Wilkins | Board Member | 3 | — |
| Jennifer Prinz | Board Member - Chair | 3 | — |
| Kevin Lee | Board Member | 3 | — |
| Mark Simon | Board Member - Vice Chair | 3 | — |
| Suzanne Conrad | Board Member - Treasurer | 3 | — |
| Contractor | Services | Paid |
|---|---|---|
| Eurofins Dpt | Laboratory Service | $4,013,109 |
| Federal Express Corporation | Shipping Service | $2,578,683 |
| North American Science Assoc | Bioassay Testing | $1,822,245 |
| Heath Duffy | Distributor Commissions | $1,622,897 |
| Stryker Sports Medecine | Distributor Commissions | $1,373,967 |
10 grants to Allosource totaling $11.4M, reported by foundations on their Schedule I filings.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Joint Restoration Foundation Inc | Grant to support joint restoration foundation's mission | 2023 | $790,852 |
| Joint Restoration Foundation Inc | Grant to support joint restoration foundation's mission | 2022 | $217,852 |
| Joint Restoration Foundation Inc | Grant to support joint restoration foundation's mission | 2021 | $694,222 |
| Joint Restoration Foundation Inc | Grant to support joint restoration foundation's mission | 2020 | $546,574 |
| Joint Restoration Foundation Inc | Grant to support joint restoration foundation's mission | 2019 | $1,865,159 |
| Joint Restoration Foundation Inc | Charitable contribution to support mission | 2018 | $577,458 |
| Joint Restoration Foundation Inc | Charitable contribution to support mission | 2017 | $1,604,560 |
| Joint Restoration Foundation Inc | Charitable contribution to support mission | 2016 | $1,492,200 |
| Joint Restoration Foundation Inc | Charitable contribution to support mission | 2015 | $2,233,500 |
| Joint Restoration Foundation Inc | Charitable contribution to support mission | 2014 | $1,373,400 |
9 grants totaling $261K in FY2024. All grants made by Allosource →
| Recipient | Purpose | Amount |
|---|---|---|
| Phoenix Society Inc | To support mission | $100,000 |
| New York Alliance For Donation Inc | To support mission | $35,000 |
| The Limb Preservation Foundation | To support mission | $33,600 |
| Mercy Ships International | To support mission | $32,675 |
| Ghana Make A Difference Inc | To support mission | $32,192 |
| Network For Hope Inc | To support mission | $10,000 |
| Donor Alliance Inc | To support mission | $6,810 |
| Arrupe Corporate Work Study Program | To support mission | $5,640 |
| Chicago Sports Summit Foundation | To support mission | $5,000 |
Explore more
Data for Allosource (EIN 84-1327507) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.